Maven Renovar VCT PLCLSE: MRV

Maven Renovar VCT: Transaction in Own Shares

· Issued by Maven Renovar VCT PLC via RNS

Summary by 6ix AI

On October 22, 2026, Maven Renovar VCT PLC, a venture capital trust, purchased 244,635 of its own Ordinary Shares at 49.50p per share, to be cancelled.

Key details

  • After the purchase, the company's issued share capital as at close of business on October 22, 2026 comprises 125,852,250 Ordinary Shares of 5p each, each carrying one voting right.
  • Shareholders may use the 125,852,250 figure as the denominator when working out whether they must notify their interest, or a change to their interest, in the company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules (the UK regulator's disclosure rules).

6ix AI wrote this summary from the release below and checked it against the release.

On 6ix: 6ix.com/news/transaction-in-own-shares-2217

Maven Renovar VCT PLC
22 October 2026
 

Maven Renovar VCT PLC (“the Company”)

Share Buy-back and Total Voting Rights

On 22 October 2026, Maven Renovar VCT PLC purchased, for cancellation, 244,635 of its own Ordinary Shares at a price of 49.50p per share.

As a result, and in accordance with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules, the Company confirms that its issued share capital as at close of business on 22 October 2026 comprises 125,852,250 Ordinary Shares of 5p each, with each share carrying one voting right.

The above figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required, under the Disclosure Guidance and Transparency Rules, to notify their interest, or a change to their interest, in the Company.

For further information, please email [email protected].

For and on behalf of the Company

Maven Capital Partners UK LLP

Tel: 0141 306 7400

22 October 2026

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Maven Renovar VCT PLC on 6ix

Earlier from Maven Renovar VCT

All Maven Renovar VCT news releases